discontinued

NB100-64513 Bacteroides spp (LPS) antibody

See related secondary antibodies

Search for all "Bacteroides spp (LPS)"

0.2 mg / €430.00

Quick Overview

Mouse anti Bacteria Bacteroides spp (LPS) 1265/30

NB100-64513

Product Description for Bacteroides spp (LPS)

Mouse anti Bacteria Bacteroides spp (LPS) 1265/30.
Presentation: Aff - Purified
Product is tested for Enzyme Immunoassay.

Properties for Bacteroides spp (LPS)

Product Category Primary Antibodies
Quantity 0.2 mg
Presentation Aff - Purified
Reactivity Bac
Applications E
Clonality Monoclonal
Clone 1265/30
Host Mouse
Isotype IgG
Shipping to Not USA/Canada
PDF datasheet View Datasheet
Manufacturer Novus Biologicals Inc.

Datasheet Extract

Immunogen
Immunogen:
LPS from B. fragilis GNABA.
Background Bacteroides fragilis is a gram-negative rod shaped bacterium. It is an obligate anaerobe and constitutes a large component (1% to 2%) of the normal colonic bacterial microflora in humans. It is an opportunistic pathogen with the potential to severely limit the success of gastro-intestinal surgery, and is frequently associated with extraintestinal infections such as abscesses and soft tissue infections, as well as diarrheal diseases in animals and humans. Lipopolysaccharide (LPS) is an integral component of the outer membrane (OM) of gram-negative bacteria. The LPS of B.fragilis substantially differs from that of other gram-negative bacteria, since it lacks 2-keto-3-deoxyoctulosonic acid and L-glycero-D-mannoheptose. The lipid A of B.fragilis does not contain 3-hydroxymyristic acid, a major fatty acid in aerobic gram-negative bacteria.
Concentration 1 mg/ml
Storage Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Format
Purification:
protein G purified
Buffer System:
0.09% Sodium Azide
Purity:
protein G purified
State:
Aff - Purified
Specificity
Specificity:
In a simple ELISA this is reactive with Bacteroides spp. Reactivities with other organisms have not yet been determined.
Species:
Bacteria

Accessory Products

  • LinkedIn